Interventional device developer Boston Scientific of Natick, MA, has entered an agreement to purchase 500,000 shares of patient-monitoring device manufacturer Aspect Medical Systems, according to the company.
As of April, Boston Scientific owned approximately 19.6% of Aspect's outstanding common stock, and may purchase an additional 25% under the terms of a stock-purchase agreement entered into in August 2002.
Aspect has a strategic alliance with Boston Scientific to introduce new sedation-management technology to interventional and specialty medical procedure suites, including the gastrointestinal endoscopy suite, the interventional cardiology suite, and the interventional radiology suite, the company said.
By AuntMinnie.com staff writersApril 9, 2004
Related Reading
Boston Scientific launches Sentinol, April 8, 2004
FDA approves Boston Scientific fibroids treatment, March 30, 2004
Boston Scientific, EndoTex complete enrollment, March 25, 2004
Boston Scientific gets FDA approval for Taxus, March 5, 2004
Boston Scientific to build intercontinental distribution center, March 4, 2004
Copyright © 2004 AuntMinnie.com
